Coloplast aktie (COLO B) | Pressmeddelande

Kerecis included on the list of covered products for Diabetic Foot Ulcers in the final LCD policy

GlobeNewswire • 14 Nov 14:22

Coloplast A/S - Notice of Annual General Meeting 2024

GlobeNewswire • 12 Nov 12:01

Coloplast A/S - Annual Report 2023/24 & Remuneration Report 2023/24

GlobeNewswire • 05 Nov 07:28

Coloplast A/S - Full-Year Financial Results 2023/24

GlobeNewswire • 05 Nov 07:26

Coloplast A/S - Announcement no. 05/2024 - Coloplast expands Executive Leadership Team

GlobeNewswire • 05 Nov 07:00

Coloplast A/S - FY 2023/24 Earnings Release - Invitation for conference call on 5 November 2024 at 11.00 CET

Coloplast A/S - FY 2023/24 Earnings Release - Invitation for conference call on 5 November 2024 at 11.

GlobeNewswire • 21 Oct 15:09

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

GlobeNewswire • 25 Sep 15:02

Coloplast A/S - Financial Calendar 2024-25

GlobeNewswire • 25 Sep 14:29

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

GlobeNewswire • 20 Sep 16:56

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

GlobeNewswire • 16 Sep 16:47

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

GlobeNewswire • 03 Sep 15:20

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

GlobeNewswire • 03 Sep 15:03

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

GlobeNewswire • 30 Aug 17:07

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

GlobeNewswire • 30 Aug 16:02

Coloplast A/S - Interim Financial Report, 9M 2023/24

GlobeNewswire • 20 Aug 07:33

Coloplast A/S - Invitation to Coloplast's Meet the Management event on 6 June 2024 (gentle reminder)

GlobeNewswire • 16 May 11:09

Coloplast expands its Luja™ portfolio with next generation catheter for women

GlobeNewswire • 14 May 09:30

Coloplast strengthens ostomy care portfolio with three significant product launches

GlobeNewswire • 07 May 07:04

Coloplast A/S - Announcement no. 02/2024 - Interim Financial Report, H1 2023/24

GlobeNewswire • 07 May 07:00

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

GlobeNewswire • 08 Mar 14:43

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

GlobeNewswire • 06 Mar 14:52

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

GlobeNewswire • 06 Mar 14:50

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

GlobeNewswire • 01 Mar 14:48

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

GlobeNewswire • 28 Feb 15:57

Coloplast A/S - Allocation of Share Options

GlobeNewswire • 09 Feb 16:18

Coloplast launches Peristeen® Light for people with bowel disorders

GlobeNewswire • 09 Feb 07:34

Coloplast A/S - Interim Financial Report, Q1 2023/24

GlobeNewswire • 09 Feb 07:30

Coloplast launches Biatain® Silicone Fit for pressure injury prevention and wound management in the US

GlobeNewswire • 31 Jan 16:00

Coloplast A/S - Q1 2023/24 Earnings Release - Invitation for conference call on 9 February 2024 at 11.00am CET

Coloplast A/S - Q1 2023/24 Earnings Release - Invitation for conference call on 9 February 2024 at 11.

GlobeNewswire • 19 Jan 10:03

Coloplast A/S - Change of auditor

GlobeNewswire • 07 Dec 2023 17:29

Coloplast A/S - Articles of Association

GlobeNewswire • 07 Dec 2023 17:27

Coloplast A/S - Decisions at the Annual General Meeting 2023

GlobeNewswire • 07 Dec 2023 17:23

Coloplast A/S - Notice of Annual General Meeting 2023

GlobeNewswire • 14 Nov 2023 11:05

Coloplast announces new manufacturing site in Portugal

GlobeNewswire • 09 Nov 2023 07:39

Coloplast A/S - Annual Report 2022/23 & Remuneration Report 2022/23

GlobeNewswire • 09 Nov 2023 07:32

Coloplast A/S - Full-Year Financial Results 2022/23

GlobeNewswire • 09 Nov 2023 07:32

Coloplast A/S - FY 2023/24 Financial Guidance

GlobeNewswire • 09 Nov 2023 07:30

Coloplast A/S - Financial Calendar 2023-24

GlobeNewswire • 12 Sep 2023 10:52

Coloplast A/S - Coloplast completes the acquisition of Kerecis - Invitation for conference call on Monday, 4 September 2023 at 14.00-15.00 CEST

Coloplast A/S - Coloplast completes the acquisition of Kerecis - Invitation for conference call on Monday, 4 September 2023 at 14.

GlobeNewswire • 01 Sep 2023 12:00

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

GlobeNewswire • 01 Sep 2023 10:56

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

GlobeNewswire • 01 Sep 2023 10:56

Coloplast A/S - Announcement no. 08/2023 - Coloplast announces registration of share capital increase of 12.2 new B shares completed

Coloplast A/S - Announcement no. 08/2023 - Coloplast announces registration of share capital increase of 12.

GlobeNewswire • 01 Sep 2023 08:21

Coloplast completes the acquisition of Kerecis

GlobeNewswire • 31 Aug 2023 15:28

Coloplast A/S - Announcement no. 07/2023 – Coloplast announces completion of offering of 12.2 million new B shares

Coloplast A/S - Announcement no. 07/2023 – Coloplast announces completion of offering of 12.

GlobeNewswire • 30 Aug 2023 02:03

Coloplast A/S - Announcement no. 06/2023 – Coloplast launches offering to raise around DKK 9 billion through issue of new B shares in a directed issue and private placement

Coloplast A/S - Announcement no. 06/2023 – Coloplast launches offering to raise around DKK 9 billion through issue of new B shares in a dire...

GlobeNewswire • 29 Aug 2023 17:01

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

GlobeNewswire • 18 Aug 2023 20:45

Major shareholder notification

GlobeNewswire • 18 Aug 2023 20:40

Coloplast A/S - Announcement no. 04/2023 - Interim Financial Report, 9M 2022/2023

GlobeNewswire • 17 Aug 2023 07:28

Coloplast A/S - Announcement no. 03/2023 - Coloplast announces agreement to acquire Kerecis and raises long-term growth expectations

GlobeNewswire • 07 Jul 2023 08:26

Largest shareholder and Foundation to secure Coloplast future with new holding company

GlobeNewswire • 21 Jun 2023 18:05

Coloplast A/S - Announcement no. 02/2023 - Interim Financial Report, H1 2022/23

GlobeNewswire • 11 May 2023 07:30

New clinical study demonstrates significant improvement in pulmonary health and related symptoms when using Provox® Life™

GlobeNewswire • 24 Apr 2023 09:30

Study shows significant improvement in bladder emptying with Coloplast's Luja™ compared to competitor catheter

GlobeNewswire • 31 Mar 2023 07:55

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

GlobeNewswire • 01 Mar 2023 14:56

Coloplast A/S - Allocation of Share Options

GlobeNewswire • 03 Feb 2023 15:01

Coloplast launches male catheter designed to reduce the risk of urinary tract infections

GlobeNewswire • 03 Feb 2023 07:35

Coloplast A/S - Announcement no. 01/2023 – Interim Financial Report, Q1 2022/23

GlobeNewswire • 03 Feb 2023 07:32

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

GlobeNewswire • 22 Dec 2022 13:32

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

GlobeNewswire • 21 Dec 2022 16:35

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

GlobeNewswire • 20 Dec 2022 20:09

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

GlobeNewswire • 06 Dec 2022 22:44

Coloplast A/S - Announcement no. 14/2022 - Articles of Association

GlobeNewswire • 01 Dec 2022 17:33

Coloplast A/S - Announcement no. 13/2022 - Decisions at the Annual General Meeting 2022

GlobeNewswire • 01 Dec 2022 17:29

Coloplast Launches New Catheter in the U.S.

Coloplast Launches New Catheter in the U.

GlobeNewswire • 18 Nov 2022 16:00

Coloplast appoints new President of its global Interventional Urology business

GlobeNewswire • 15 Nov 2022 16:00

Coloplast enters into Power Purchase Agreement with Better Energy

GlobeNewswire • 10 Nov 2022 10:00

Coloplast A/S - Announcement no. 12/2022 - Notice of Annual General Meeting

GlobeNewswire • 08 Nov 2022 13:59

Coloplast A/S - Announcement no. 11/2022 - Sustainability Report 2021/22

GlobeNewswire • 07 Nov 2022 18:19

Coloplast A/S - Announcement no. 10/2022 - Annual Report 2021/22 & Remuneration Report 2021/22

GlobeNewswire • 07 Nov 2022 18:09

Coloplast A/S Announcement no. 9/2022 - Full-Year Financial Results 2021/22

GlobeNewswire • 07 Nov 2022 13:05

Coloplast launches Saffron™ Fixation System for Prolapse Repair

GlobeNewswire • 06 Oct 2022 16:00

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

GlobeNewswire • 14 Sep 2022 16:34

Coloplast A/S - Announcement no. 08/2022 - Financial Calendar 2022-23

GlobeNewswire • 08 Sep 2022 16:41

Coloplast A/S - Meet the Management event

GlobeNewswire • 31 Aug 2022 10:00

Coloplast A/S - Announcement no. 07/2022 - Interim Financial Report, 9M 2021/2022

GlobeNewswire • 17 Aug 2022 12:16

Coloplast A/S - Reminder: Coloplast's Meet the Management event on 31 August 2022 - register by 5 August 2022

GlobeNewswire • 28 Jul 2022 11:39

Coloplast awarded AscenDrive Agreement for Ostomy Products with Premier, Inc.

GlobeNewswire • 30 Jun 2022 16:00

New informational website around larynx cancer surgery

GlobeNewswire • 17 May 2022 10:30

Announcement no. 06/2022 - Coloplast announces the successful issuance of EUR 2.2 billion senior notes under its Euro Medium Term Note programme

Announcement no. 06/2022 - Coloplast announces the successful issuance of EUR 2.

GlobeNewswire • 11 May 2022 18:54

Announcement no. 05/2022 - Coloplast announces the establishment of its Euro Medium Term Note programme

GlobeNewswire • 09 May 2022 10:46

Coloplast delivers a solid Q2 with 7% organic growth and a 31% EBIT margin and revises full year organic growth guidance to 6-7% from around 7%

Coloplast delivers a solid Q2 with 7% organic growth and a 31% EBIT margin and revises full year organic growth guidance to 6-7% from around...

GlobeNewswire • 05 May 2022 12:05

Coloplast A/S - Announcement no. 04/2022 – Interim Financial Report, H1 2021/22

GlobeNewswire • 05 May 2022 12:02

Coloplast A/S - Transactions in connection with share buy-back programme, week 16 (programme completed)

GlobeNewswire • 25 Apr 2022 10:34

Coloplast A/S - Transactions in connection with share buy-back programme, week 15

GlobeNewswire • 19 Apr 2022 10:51

Coloplast A/S - Transactions in connection with share buy-back programme, week 14

GlobeNewswire • 11 Apr 2022 10:47

Coloplast A/S - Transactions in connection with share buy-back programme, week 13

GlobeNewswire • 04 Apr 2022 11:05

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

GlobeNewswire • 31 Mar 2022 21:44

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

GlobeNewswire • 31 Mar 2022 21:34

Coloplast A/S - Transactions in connection with share buy-back programme, week 12

GlobeNewswire • 28 Mar 2022 11:40

New randomized crossover study shows significant improvements in pulmonary symptoms for patients with total laryngectomy when switching to new product range

New randomized crossover study shows significant improvements in pulmonary symptoms for patients with total laryngectomy when switching to n...

GlobeNewswire • 23 Mar 2022 12:01

Coloplast A/S - Transactions in connection with share buy-back programme, week 11

GlobeNewswire • 21 Mar 2022 10:26

Coloplast A/S - Transactions in connection with share buy-back programme, week 10

GlobeNewswire • 14 Mar 2022 11:30

Coloplast A/S - Transactions in connection with share buy-back programme, week 9

GlobeNewswire • 07 Mar 2022 10:36

Coloplast A/S - Transactions in connection with share buy-back programme, week 8

GlobeNewswire • 28 Feb 2022 12:02

Coloplast A/S - Announcement no. 03/2022 - Share Buyback Programme

GlobeNewswire • 18 Feb 2022 10:26

Coloplast A/S - Coloplast completes the acquisition of Atos Medical

GlobeNewswire • 31 Jan 2022 15:16

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

GlobeNewswire • 26 Jan 2022 15:55

Coloplast A/S - Allocation of Share Options

GlobeNewswire • 25 Jan 2022 13:08

Coloplast delivers solid start to the year with 6% organic growth in Q1 and a 32% EBIT margin before special items

GlobeNewswire • 25 Jan 2022 12:10

Coloplast A/S - Announcement no. 01/2022 – Interim Financial Report, Q1 2021/22

GlobeNewswire • 25 Jan 2022 12:06

Börskollen

För dig med koll på börsen

Pressmeddelanden från Coloplast

Kerecis included on the list of covered products for Diabetic Foot Ulcers in the final LCD policy

Coloplast A/S - Notice of Annual General Meeting 2024

Coloplast A/S - Annual Report 2023/24 & Remuneration Report 2023/24

Coloplast A/S - Full-Year Financial Results 2023/24

Coloplast A/S - Announcement no. 05/2024 - Coloplast expands Executive Leadership Team

Coloplast A/S - FY 2023/24 Earnings Release - Invitation for conference call on 5 November 2024 at 11.00 CET

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

Coloplast A/S - Financial Calendar 2024-25

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

Coloplast A/S - Interim Financial Report, 9M 2023/24

Coloplast A/S - Invitation to Coloplast's Meet the Management event on 6 June 2024 (gentle reminder)

Coloplast expands its Luja™ portfolio with next generation catheter for women

Coloplast strengthens ostomy care portfolio with three significant product launches

Coloplast A/S - Announcement no. 02/2024 - Interim Financial Report, H1 2023/24

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

Coloplast A/S - Allocation of Share Options

Coloplast launches Peristeen® Light for people with bowel disorders

Coloplast A/S - Interim Financial Report, Q1 2023/24

Coloplast launches Biatain® Silicone Fit for pressure injury prevention and wound management in the US

Coloplast A/S - Q1 2023/24 Earnings Release - Invitation for conference call on 9 February 2024 at 11.00am CET

Coloplast A/S - Change of auditor

Coloplast A/S - Articles of Association

Coloplast A/S - Decisions at the Annual General Meeting 2023

Coloplast A/S - Notice of Annual General Meeting 2023

Coloplast announces new manufacturing site in Portugal

Coloplast A/S - Annual Report 2022/23 & Remuneration Report 2022/23

Coloplast A/S - Full-Year Financial Results 2022/23

Coloplast A/S - FY 2023/24 Financial Guidance

Coloplast A/S - Financial Calendar 2023-24

Coloplast A/S - Coloplast completes the acquisition of Kerecis - Invitation for conference call on Monday, 4 September 2023 at 14.00-15.00 CEST

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

Coloplast A/S - Announcement no. 08/2023 - Coloplast announces registration of share capital increase of 12.2 new B shares completed

Coloplast completes the acquisition of Kerecis

Coloplast A/S - Announcement no. 07/2023 – Coloplast announces completion of offering of 12.2 million new B shares

Coloplast A/S - Announcement no. 06/2023 – Coloplast launches offering to raise around DKK 9 billion through issue of new B shares in a directed issue and private placement

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

Major shareholder notification

Coloplast A/S - Announcement no. 04/2023 - Interim Financial Report, 9M 2022/2023

Coloplast A/S - Announcement no. 03/2023 - Coloplast announces agreement to acquire Kerecis and raises long-term growth expectations

Largest shareholder and Foundation to secure Coloplast future with new holding company

Coloplast A/S - Announcement no. 02/2023 - Interim Financial Report, H1 2022/23

New clinical study demonstrates significant improvement in pulmonary health and related symptoms when using Provox® Life™

Study shows significant improvement in bladder emptying with Coloplast's Luja™ compared to competitor catheter

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

Coloplast A/S - Allocation of Share Options

Coloplast launches male catheter designed to reduce the risk of urinary tract infections

Coloplast A/S - Announcement no. 01/2023 – Interim Financial Report, Q1 2022/23

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

Coloplast A/S - Announcement no. 14/2022 - Articles of Association

Coloplast A/S - Announcement no. 13/2022 - Decisions at the Annual General Meeting 2022

Coloplast Launches New Catheter in the U.S.

Coloplast appoints new President of its global Interventional Urology business

Coloplast enters into Power Purchase Agreement with Better Energy

Coloplast A/S - Announcement no. 12/2022 - Notice of Annual General Meeting

Coloplast A/S - Announcement no. 11/2022 - Sustainability Report 2021/22

Coloplast A/S - Announcement no. 10/2022 - Annual Report 2021/22 & Remuneration Report 2021/22

Coloplast A/S Announcement no. 9/2022 - Full-Year Financial Results 2021/22

Coloplast launches Saffron™ Fixation System for Prolapse Repair

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

Coloplast A/S - Announcement no. 08/2022 - Financial Calendar 2022-23

Coloplast A/S - Meet the Management event

Coloplast A/S - Announcement no. 07/2022 - Interim Financial Report, 9M 2021/2022

Coloplast A/S - Reminder: Coloplast's Meet the Management event on 31 August 2022 - register by 5 August 2022

Coloplast awarded AscenDrive Agreement for Ostomy Products with Premier, Inc.